These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11126514)

  • 1. Immunological properties of Hn-33 purified from type A Clostridium botulinum.
    Sharma SK; Singh BR
    J Nat Toxins; 2000 Nov; 9(4):357-62. PubMed ID: 11126514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological characterization of the subunits of type A botulinum neurotoxin and different components of its associated proteins.
    Kukreja R; Chang TW; Cai S; Lindo P; Riding S; Zhou Y; Ravichandran E; Singh BR
    Toxicon; 2009 May; 53(6):616-24. PubMed ID: 19673075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II.
    Zhou Y; Foss S; Lindo P; Sarkar H; Singh BR
    FEBS J; 2005 Jun; 272(11):2717-26. PubMed ID: 15943806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemagglutinin binding mediated protection of botulinum neurotoxin from proteolysis.
    Sharma SK; Singh BR
    J Nat Toxins; 1998 Oct; 7(3):239-53. PubMed ID: 9783262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunochemical characteristics of botulinum neurotoxin type A and its associated proteins.
    Bryant AM; Cai S; Singh BR
    Toxicon; 2013 Sep; 72():126-32. PubMed ID: 23811077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protease-resistant novel hemagglutinin purified from type A Clostridium botulinum.
    Fu FN; Sharma SK; Singh BR
    J Protein Chem; 1998 Jan; 17(1):53-60. PubMed ID: 9491928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time PCR detection of the nontoxic nonhemagglutinin gene as a rapid screening method for bacterial isolates harboring the botulinum neurotoxin (A-G) gene complex.
    Raphael BH; Andreadis JD
    J Microbiol Methods; 2007 Dec; 71(3):343-6. PubMed ID: 17961766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of neurotoxin and hemagglutinin from Clostridium botulinum A and characterization of its neurotoxin].
    Vinogradova ID; Uvarova RN; Ivanov KK; Kazdobina IS; Bulatova TI
    Biokhimiia; 1983 May; 48(5):788-96. PubMed ID: 6409167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular properties of a hemagglutinin purified from type A Clostridium botulinum.
    Sharma SK; Fu FN; Singh BR
    J Protein Chem; 1999 Jan; 18(1):29-38. PubMed ID: 10071926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular structure and immunochemical properties of highly purified hemagglutinin from Clostridium botulinum type A].
    Ivanova LG; Blagoveshchenskiĭ VA; Vinogradova ID; Kolesnikova VA; Ugriumova GA
    Biokhimiia; 1983 Sep; 48(9):1548-54. PubMed ID: 6414537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of six monoclonal antibodies to hemagglutinin-70 of Clostridium botulinum and their application in a sandwich ELISA.
    Scotcher MC; Cheng LW; Ching K; McGarvey J; Hnasko R; Stanker L
    Monoclon Antib Immunodiagn Immunother; 2013 Feb; 32(1):6-15. PubMed ID: 23600499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A.
    Wu HC; Yeh CT; Huang YL; Tarn LJ; Lung CC
    Appl Environ Microbiol; 2001 Jul; 67(7):3201-7. PubMed ID: 11425742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947.
    Kouguchi H; Suzuki T; Hasegawa K; Mutoh S; Watanabe T; Niwa K; Yoneyama T; Katoh Y; Ohyama T
    J Microbiol Methods; 2006 Dec; 67(3):416-23. PubMed ID: 16725219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an immunodetection test for a botulinum-like neurotoxin produced by Clostridium sp. RKD.
    Dixit A; Alam SI; Dhaked RK; Singh L
    Indian J Med Res; 2006 Sep; 124(3):355-62. PubMed ID: 17085839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive sandwich enzyme immunoassay for free or complexed Clostridium botulinum neurotoxin type A.
    Volland H; Lamourette P; Nevers MC; Mazuet C; Ezan E; Neuburger LM; Popoff M; Créminon C
    J Immunol Methods; 2008 Jan; 330(1-2):120-9. PubMed ID: 18093612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete subunit structure of the Clostridium botulinum type D toxin complex via intermediate assembly with nontoxic components.
    Mutoh S; Kouguchi H; Sagane Y; Suzuki T; Hasegawa K; Watanabe T; Ohyama T
    Biochemistry; 2003 Sep; 42(37):10991-7. PubMed ID: 12974634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A.
    Chao HY; Wang YC; Tang SS; Liu HW
    Toxicon; 2004 Jan; 43(1):27-34. PubMed ID: 15037026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of C-terminal region of HA-33 component of botulinum toxin in hemagglutination.
    Sagane Y; Kouguchi H; Watanabe T; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    Biochem Biophys Res Commun; 2001 Nov; 288(3):650-7. PubMed ID: 11676492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.